HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $735,158 | +452.8% | 294,063 | +828.0% | 0.00% | – |
| Q3 2022 | $133,000 | -90.5% | 31,689 | -93.7% | 0.00% | -100.0% |
| Q2 2022 | $1,405,000 | -74.5% | 503,685 | -16.4% | 0.01% | -73.7% |
| Q4 2021 | $5,502,000 | +7.1% | 602,613 | +25.3% | 0.02% | -9.5% |
| Q3 2021 | $5,139,000 | -15.4% | 480,772 | +22.8% | 0.02% | -27.6% |
| Q2 2021 | $6,075,000 | +29.7% | 391,433 | +104.2% | 0.03% | -6.5% |
| Q1 2019 | $4,685,000 | +71.7% | 191,698 | +82.2% | 0.03% | +55.0% |
| Q4 2018 | $2,729,000 | -72.7% | 105,205 | -66.6% | 0.02% | -55.6% |
| Q3 2018 | $9,984,000 | -83.2% | 315,454 | -85.3% | 0.04% | -81.9% |
| Q1 2018 | $59,333,000 | +101.1% | 2,149,740 | +31.9% | 0.25% | +169.6% |
| Q4 2017 | $29,501,000 | +60.0% | 1,629,881 | +42.7% | 0.09% | +27.8% |
| Q3 2017 | $18,443,000 | +9.0% | 1,141,955 | -6.5% | 0.07% | +2.9% |
| Q2 2017 | $16,916,000 | -5.8% | 1,221,403 | +2.1% | 0.07% | -16.7% |
| Q1 2017 | $17,951,000 | – | 1,196,715 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |